Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,329 | -19,824 | -64,923 | -45,128 | -30,514 |
| Depreciation Amortization | 209 | 102 | 454 | 352 | 242 |
| Accounts receivable | -477 | 742 | 6,138 | 6,810 | 7,155 |
| Accounts payable and accrued liabilities | 2,355 | 1,513 | 8,447 | 4,484 | 4,107 |
| Other Working Capital | -3,046 | -1,625 | 2,672 | -564 | -1,176 |
| Other Operating Activity | 4,292 | 943 | 99 | 64 | -2,864 |
| Operating Cash Flow | $-37,996 | $-18,149 | $-47,113 | $-33,982 | $-23,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -13 | -111 | -87 | -64 |
| Purchase Of Investment | -60,598 | -51,669 | -39,732 | -35,124 | -29,926 |
| Sale Of Investment | 40,000 | 20,750 | 89,041 | 74,040 | 54,989 |
| Other Investing Activity | 0 | 0 | -833 | -833 | -833 |
| Investing Cash Flow | $-20,669 | $-30,932 | $48,365 | $37,996 | $24,166 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58,145 | 58,031 | N/A | 0 | N/A |
| Other Financing Activity | -273 | -250 | -5,862 | -3,328 | -284 |
| Financing Cash Flow | $57,872 | $57,781 | $-5,862 | $-3,328 | $-284 |
| Beginning Cash Position | 19,960 | 19,960 | 24,570 | 24,570 | 24,570 |
| End Cash Position | 19,167 | 28,660 | 19,960 | 25,256 | 25,402 |
| Net Cash Flow | $-793 | $8,700 | $-4,610 | $686 | $832 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,996 | -18,149 | -47,113 | -33,982 | -23,050 |
| Capital Expenditure | -71 | -13 | -111 | -87 | -64 |
| Free Cash Flow | -38,067 | -18,162 | -47,224 | -34,069 | -23,114 |